Search research articles
Contact Us
Filters
Showing results (291-300 of 312) with videos related to
Page
of 32
Sort By:
Journal of Lipid Research
|
December 28, 2012
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice
Julia M Assini, Erin E Mulvihill, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 17, 2018
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (<i>LDLR</i><sup>+/-</sup> and <i>LDLR</i><sup>-/-</sup>) Yucatan Miniature Pigs
Amy C Burke, Dawn E Telford, Brian G Sutherland, et al.
Journal of Medicinal Chemistry
|
February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives
G E Stokker, A W Alberts, P S Anderson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 16, 2021
Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia
Nadya M Morrow, Natasha A Trzaskalski, Antonio A Hanson, et al.
Journal of Lipid Research
|
October 9, 2009
APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians
Piya Lahiry, Henian Cao, Matthew R Ban, et al.
Journal of Medicinal Chemistry
|
March 1, 1985
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives
G E Stokker, W F Hoffman, A W Alberts, et al.
Journal of Medicinal Chemistry
|
February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives
W F Hoffman, A W Alberts, E J Cragoe, et al.
Journal of Lipid Research
|
January 23, 2020
The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK
Nadya M Morrow, Amy C Burke, Joshua P Samsoondar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 26, 2013
Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice
Lazar A Bojic, Amy C Burke, Sanjiv S Chhoker, et al.
Journal of Lipid Research
|
May 28, 2014
PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
Lazar A Bojic, Dawn E Telford, Morgan D Fullerton, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 312) with videos related to
Sort By:
Page
of 32
Journal of Lipid Research
|
December 28, 2012
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice
Julia M Assini, Erin E Mulvihill, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 17, 2018
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (<i>LDLR</i><sup>+/-</sup> and <i>LDLR</i><sup>-/-</sup>) Yucatan Miniature Pigs
Amy C Burke, Dawn E Telford, Brian G Sutherland, et al.
Journal of Medicinal Chemistry
|
February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives
G E Stokker, A W Alberts, P S Anderson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 16, 2021
Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia
Nadya M Morrow, Natasha A Trzaskalski, Antonio A Hanson, et al.
Journal of Lipid Research
|
October 9, 2009
APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians
Piya Lahiry, Henian Cao, Matthew R Ban, et al.
Journal of Medicinal Chemistry
|
March 1, 1985
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives
G E Stokker, W F Hoffman, A W Alberts, et al.
Journal of Medicinal Chemistry
|
February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives
W F Hoffman, A W Alberts, E J Cragoe, et al.
Journal of Lipid Research
|
January 23, 2020
The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK
Nadya M Morrow, Amy C Burke, Joshua P Samsoondar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 26, 2013
Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice
Lazar A Bojic, Amy C Burke, Sanjiv S Chhoker, et al.
Journal of Lipid Research
|
May 28, 2014
PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
Lazar A Bojic, Dawn E Telford, Morgan D Fullerton, et al.
Page
of 32